PHATHOM PHARMACEUTICALS, INC. (PHAT) Social Stream
PHATHOM PHARMACEUTICALS INC (PHAT) Price Targets From Analysts
Use the tables below to see what analysts covering PHATHOM PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 2 | $59 | $59 | $59 | $7.68 | 668.23% |
| 2022-05-10 | 2 | $48 | $48 | $48 | $7.68 | 525% |
| 2022-05-24 | 3 | $15 | $15 | $15 | $7.68 | 95.31% |
| 2022-08-03 | 3 | $45 | $9 | $30.666 | $7.68 | 299.3% |
| 2022-10-21 | 4 | $45 | $9 | $27 | $7.68 | 251.56% |
| 2022-11-11 | 6 | $45 | $9 | $27.6 | $7.68 | 259.38% |
| 2022-11-14 | 6 | $38 | $9 | $26.2 | $7.68 | 241.15% |
| 2023-01-04 | 6 | $35 | $9 | $22.6 | $7.68 | 194.27% |
| 2023-02-10 | 6 | $35 | $9 | $22.2 | $7.68 | 189.06% |
| 2023-03-01 | 6 | $30 | $9 | $21.2 | $7.68 | 176.04% |
| 2023-04-19 | 6 | $30 | $9 | $21.166 | $7.68 | 175.6% |
| 2023-05-11 | 6 | $30 | $9 | $19.6 | $7.68 | 155.21% |
| 2023-08-11 | 6 | $30 | $20 | $24.4 | $7.68 | 217.71% |
| 2023-11-10 | 6 | $28 | $20 | $23 | $7.68 | 199.48% |
| 2023-11-28 | 7 | $28 | $9 | $20.666 | $7.68 | 169.09% |
The Trend in the Analyst Price Target
Over the past 29 months, PHAT's average price target has gone down $37.5.
Over the past 42 weeks, PHAT's average upside potential has been 113.95%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-19 | 7 | 30 | 9 | 21.166 | 10.72 | 97.44% |
| 2023-05-11 | 6 | 30 | 9 | 19.600 | 13.19 | 48.6% |
| 2023-05-11 | 5 | 30 | 9 | 21.333 | 13.19 | 61.74% |
| 2023-05-11 | 5 | 30 | 15 | 22.250 | 13.19 | 68.69% |
| 2023-10-10 | 6 | 28 | 20 | 23.000 | 10.71 | 114.75% |
PHAT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.43 | 5 | 1 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
PHAT's average broker recommendation rating improved by 0.28 over the prior 31 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PHAT as an investment opportunity.
- In the context of all US stocks, PHATHOM PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 2765.61% of them.
- In terms of how PHATHOM PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1593.56% of that group.
- In terms of how PHATHOM PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 570.73% of that group.
- PHAT has a higher average analyst price target than 2169.24% of stocks in the small market cap category.
In the Pharmaceutical Products industry, TFFP, PROC, and THTX are the three stocks most similar to PHATHOM PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for PHAT? Use POWR Ratings for clearer insight into price direction.